TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 24902020

Group type: EXPERIMENTAL
Intervention: Iron supplementation in GDM group
Number of subjects: 52

Group type: COMPARATOR
Intervention: Control group (normoglycemic women)
Number of subjects: 52
Study: 22388476

Group type: EXPERIMENTAL
Intervention: Active treatment (medication or cognitive-behavioral therapy)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Remission of mothers' depression (regardless of treatment assignment)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Referral to existing community services
Number of subjects: 60
Study: 19699049

Group type: EXPERIMENTAL
Intervention: SMART group (technology-based weight reduction program)
Number of subjects: 111

Group type: COMPARATOR
Intervention: Usual care group (standard nutritional program)
Number of subjects: 111
Study: 18755319

Group type: EXPERIMENTAL
Intervention: 1,000 mg calcium carbonate plus 400 IU vitamin D(3) per day
Number of subjects: 33067

Group type: COMPARATOR
Intervention: Matching placebo pills
Number of subjects: 33067
Study: 15653998

Group type: EXPERIMENTAL
Intervention: Buffered reduced glutathione (GSH)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo (sodium chloride with a hint of quinine)
Number of subjects: 19
Study: 12843166

Group type: EXPERIMENTAL
Intervention: Intensive insulin treatment
Number of subjects: 80

Group type: COMPARATOR
Intervention: Conventional insulin treatment
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Not specified
Number of subjects: 80
Study: 10029341

Group type: EXPERIMENTAL
Intervention: Oxygen supplementation with F(I)O2 of 0.40
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (healthy controls) with F(I)O2 of 0.40
Number of subjects: 9

Group type: EXPERIMENTAL
Intervention: Oxygen supplementation with F(I)O2 of 0.21
Number of subjects: 9

Group type: COMPARATOR
Intervention: Control group (healthy controls) with F(I)O2 of 0.21
Number of subjects: 9
Study: 8743187

Group type: EXPERIMENTAL
Intervention: Oral anticoagulation for 6 months
Number of subjects: 991

Group type: COMPARATOR
Intervention: No anticoagulation or shorter duration
Number of subjects: 991
Study: 1662562

Group type: EXPERIMENTAL
Intervention: Enalapril 10 mg once daily
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Lisinopril 10 mg once daily
Number of subjects: 12
Study: 6356756

Group type: EXPERIMENTAL
Intervention: Midazolam (0.13 mg/kg)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diazepam (0.17 mg/kg)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Midazolam
Number of subjects: 60

Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 60
Study: 31868067

Group type: EXPERIMENTAL
Intervention: Vignettes depicting an individual addicted to opioids as either Black or White, male or female, and working‐ or middle‐class.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Attributing addiction to bad character.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: User or participant gender.
Number of subjects: 0
Study: 31794587

Group type: EXPERIMENTAL
Intervention: Robot-assisted UKA
Number of subjects: 112

Group type: COMPARATOR
Intervention: Conventional UKA
Number of subjects: 112
Study: 29595123

Group type: EXPERIMENTAL
Intervention: Fixed-dose combination formulation (salbutamol 4 mg and ambroxol 15 mg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Co-administration of salbutamol 4 mg and ambroxol 15 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Salbutamol 4 mg
Number of subjects: 24

Group type: COMPARATOR
Intervention: Ambroxol 15 mg
Number of subjects: 24
Study: 27919965

Group type: EXPERIMENTAL
Intervention: Bevacizumab combined with docetaxel (10 mg/kg bevacizumab i.v. plus 50 mg/m2 docetaxel i.v.)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Bevacizumab combined with paclitaxel (10 mg/kg bevacizumab i.v. plus 90 mg/m2 paclitaxel i.v.)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Bevacizumab (15 mg/kg i.v.) alone after progression
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Bevacizumab-related serious adverse events
Number of subjects: 65
Study: 24838177

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg once daily for 5 days (Period 1)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dolutegravir 50 mg once daily coadministered with telaprevir 750 mg every 8 h for 10 days (Period 2)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Coadministration of dolutegravir with boceprevir or telaprevir
Number of subjects: 0

Group type: COMPARATOR
Intervention: Historical data for boceprevir and telaprevir
Number of subjects: 0
Study: 22542365

Group type: EXPERIMENTAL
Intervention: 1500 IU/day antithrombin (AT) supplementation for 3 days
Number of subjects: 729

Group type: EXPERIMENTAL
Intervention: 3000 IU/day antithrombin (AT) supplementation for 3 days
Number of subjects: 729

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 729
Study: 19996954

Group type: EXPERIMENTAL
Intervention: 0.5 ml of bupivacaine mixed with contrast
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: 0.25 ml of bupivacaine mixed with contrast
Number of subjects: 24

Group type: COMPARATOR
Intervention: Prone position
Number of subjects: 24

Group type: COMPARATOR
Intervention: Lateral approach
Number of subjects: 24
Study: 17511185

Group type: EXPERIMENTAL
Intervention: 2.5 mg sufentanil and 2.5 mg bupivacaine
Number of subjects: 40

Group type: COMPARATOR
Intervention: 25 mg tramadol and 2.5 mg bupivacaine
Number of subjects: 40
Study: 15895421

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS, 15 Hz, 110% above motor threshold, 10 daily sessions)
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Fluoxetine (20 mg/day)
Number of subjects: 25

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 25
Study: 11840381

Group type: EXPERIMENTAL
Intervention: Potassium citrate 4 mEq/kg/d
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Potassium citrate 2 mEq/kg/d to 3 mEq/kg/d
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Potassium citrate (various dosages)
Number of subjects: 8
Study: 10852285

Group type: EXPERIMENTAL
Intervention: Teaching by patient partners
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Teaching by rheumatology fellows
Number of subjects: 80

Group type: COMPARATOR
Intervention: Teaching by patient partners (Group 3A)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Teaching by rheumatology trainees (Group 3B)
Number of subjects: 80
Study: 8801202

Group type: EXPERIMENTAL
Intervention: Mesalazine foam enema
Number of subjects: 295

Group type: COMPARATOR
Intervention: Prednisolone foam enema
Number of subjects: 295
Study: 1355797

Group type: EXPERIMENTAL
Intervention: 5 mg zinc daily
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 57
Study: 6833501

Group type: EXPERIMENTAL
Intervention: Cardiovascular risk reduction education program
Number of subjects: 24
Study: 30025953

Group type: EXPERIMENTAL
Intervention: Nurse-led program for comorbidities management
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Current treatment with NSAIDs and biologics
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Multimorbidity index assessing the number of morbid conditions
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Female gender
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Disease activity and mHAQ
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Physical activity
Number of subjects: 962

Group type: EXPERIMENTAL
Intervention: Obesity and anxiety/depression
Number of subjects: 962
Study: 29558161

Group type: EXPERIMENTAL
Intervention: Jump training with normal body weight (JTBW)
Number of subjects: 19

Group type: COMPARATOR
Intervention: High-repetition jump training with body weight support (JTBWS)
Number of subjects: 19
Study: 26989846

Group type: EXPERIMENTAL
Intervention: Telmisartan/Amlodipine combination tablets (bedtime administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telmisartan/Amlodipine combination tablets (morning administration)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Telmisartan/Amlodipine combination tablets (both timings)
Number of subjects: 0
Study: 24061071

Group type: EXPERIMENTAL
Intervention: Concord grape juice (CGJ)
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 26
Study: 21448129

Group type: EXPERIMENTAL
Intervention: Intensive behavioral weight loss intervention (22 group sessions over 26 weeks)
Number of subjects: 472

Group type: EXPERIMENTAL
Intervention: Intensive behavioral weight loss intervention
Number of subjects: 472
Study: 20600809

Group type: EXPERIMENTAL
Intervention: Healing Touch (HT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Relaxation Training (RT)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 60
Study: 17959080

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Clopidogrel
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 40
Study: 16097900

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 109

Group type: COMPARATOR
Intervention: General health education (GHE)
Number of subjects: 109
Study: 12073203

Group type: EXPERIMENTAL
Intervention: Heparin-coated circuits with reduced systemic heparinization
Number of subjects: 90

Group type: COMPARATOR
Intervention: Heparin-coated circuits with full systemic heparinization
Number of subjects: 90

Group type: COMPARATOR
Intervention: Conventional circuits with full systemic heparinization
Number of subjects: 90
Study: 11899264

Group type: EXPERIMENTAL
Intervention: Chronic painful tendinosis (Achilles, patellar, ECRB)
Number of subjects: 0
Study: 9647875

Group type: EXPERIMENTAL
Intervention: CHOP plus radiotherapy
Number of subjects: 401

Group type: COMPARATOR
Intervention: CHOP alone
Number of subjects: 401
Study: 8011007

Group type: EXPERIMENTAL
Intervention: New sustained‐release metoclopramide (Cronoprimperan)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Standard formulation (Primperan)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Both medications
Number of subjects: 12
Study: 2679289

Group type: EXPERIMENTAL
Intervention: Antiplatelet or anticoagulant therapy, early initiation
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Active treatment
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo or nonplacebo control
Number of subjects: 0
Study: 766619

Group type: EXPERIMENTAL
Intervention: 0.25 g hydrocortisone hemisuccinate
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 0.50 g hydrocortisone hemisuccinate
Number of subjects: 38

Group type: EXPERIMENTAL
Intervention: 1.0 g hydrocortisone hemisuccinate
Number of subjects: 38

Group type: COMPARATOR
Intervention: Placebo (sterile saline solution)
Number of subjects: 38
Study: 7312235

Group type: COMPARATOR
Intervention: Conventional paracervical block (almost simultaneous injection of the 2 sides)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Paracervical block with a 10-minute interval between injections
Number of subjects: 42
Study: 31567719

Group type: EXPERIMENTAL
Intervention: Full bench press (BPFULL)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Two-thirds bench press (BP2/3)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: One-third bench press (BP1/3)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Control (training cessation)
Number of subjects: 50
Study: 31649322

Group type: EXPERIMENTAL
Intervention: Increased educational attainment (EA)
Number of subjects: 780000
Study: 31394412

Group type: EXPERIMENTAL
Intervention: Value-affirmation and goals task (VAG)
Number of subjects: 171

Group type: EXPERIMENTAL
Intervention: Value-affirmation task (VA)
Number of subjects: 171

Group type: COMPARATOR
Intervention: Non-affirmation control task (NAC)
Number of subjects: 171
Study: 29794277

Group type: EXPERIMENTAL
Intervention: IV ketamine (LDK) 1 mg/kg
Number of subjects: 240

Group type: COMPARATOR
Intervention: IV morphine (MOR) 0.1 mg/kg
Number of subjects: 240
Study: 25773139

Group type: EXPERIMENTAL
Intervention: CABG + BMMNC
Number of subjects: 42

Group type: COMPARATOR
Intervention: CABG
Number of subjects: 42
Study: 24590745

Group type: EXPERIMENTAL
Intervention: Belief that thirdhand smoke is harmful
Number of subjects: 1947
Study: 22455355

Group type: EXPERIMENTAL
Intervention: Ethanol (0.25 g/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ethanol (0.5 g/kg)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Ethanol (0.75 g/kg)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study: 20471179

Group type: EXPERIMENTAL
Intervention: Reactivation/Stress group
Number of subjects: 47

Group type: COMPARATOR
Intervention: Reactivation/No Stress group
Number of subjects: 47

Group type: COMPARATOR
Intervention: No Reactivation/Stress group
Number of subjects: 47
Study: 18240258

Group type: COMPARATOR
Intervention: Anti-TNFα treatment in PsA
Number of subjects: 1268

Group type: COMPARATOR
Intervention: Anti-TNFα treatment in AS
Number of subjects: 1268

Group type: EXPERIMENTAL
Intervention: Anti-TNFα treatment in RA
Number of subjects: 1268

Group type: EXPERIMENTAL
Intervention: Concomitant MTX in RA and PsA
Number of subjects: 1268

Group type: COMPARATOR
Intervention: Concomitant MTX in AS
Number of subjects: 1268

Group type: EXPERIMENTAL
Intervention: HRQOL improvements in PsA and AS
Number of subjects: 1268
Study: 15886531

Group type: EXPERIMENTAL
Intervention: Interventions to decrease stroke risk in diabetic and hypertensive patients
Number of subjects: 0
Study: 12442933

Group type: EXPERIMENTAL
Intervention: Cisatracurium (intubation dose 0.1 mg kg(‐1))
Number of subjects: 30

Group type: COMPARATOR
Intervention: Atracurium (0.5 mg kg(‐1))
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cisatracurium (effective dose 0.05 mg kg(‐1))
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Cisatracurium (repeat dose 0.02 mg kg(‐1))
Number of subjects: 30
Study: 10350246

Group type: EXPERIMENTAL
Intervention: High-dose tirilazad mesylate (15 mg/kg/day)
Number of subjects: 823

Group type: COMPARATOR
Intervention: Placebo vehicle
Number of subjects: 823
Study: 8961907

Group type: EXPERIMENTAL
Intervention: Sulfasalazine (SSZ) at a dosage of 2,000 mg/day
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 1756842

Group type: EXPERIMENTAL
Intervention: Nebulized salbutamol
Number of subjects: 22

Group type: COMPARATOR
Intervention: Nebulized saline (placebo)
Number of subjects: 22
Study: 6803633

Group type: EXPERIMENTAL
Intervention: Hypnosis
Number of subjects: 10

Group type: COMPARATOR
Intervention: Control exercise challenges (no treatment)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Cromolyn (pretreatment)
Number of subjects: 10
Study: 28853296

Group type: EXPERIMENTAL
Intervention: Art participation sessions (n=41)
Number of subjects: 81

Group type: COMPARATOR
Intervention: Usual care (n=40)
Number of subjects: 81
Study: 29677164

Group type: EXPERIMENTAL
Intervention: Greater adherence to the French nutritional recommendations (measured by PNNS‐GS)
Number of subjects: 2249

Group type: EXPERIMENTAL
Intervention: BMI status (mediator)
Number of subjects: 2249
Study: 26555886

Group type: EXPERIMENTAL
Intervention: Real rTMS (10 Hz, 2000 pulses divided into 20 trains with one-sec inter-train interval)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Real rTMS
Number of subjects: 24

Group type: COMPARATOR
Intervention: Sham rTMS
Number of subjects: 24
Study: 24574935

Group type: EXPERIMENTAL
Intervention: Scoliosis-specific therapeutic exercise program
Number of subjects: 144

Group type: COMPARATOR
Intervention: Observation for idiopathic scoliosis
Number of subjects: 144
Study: 22931315

Group type: EXPERIMENTAL
Intervention: Clopidogrel (75 mg daily) + Aspirin (325 mg daily)
Number of subjects: 3020

Group type: COMPARATOR
Intervention: Aspirin (325 mg daily)
Number of subjects: 3020
Study: 20405783

Group type: EXPERIMENTAL
Intervention: Isometric contraction at 30% of isometric maximal voluntary contraction (MVC)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Isometric contraction at 60% of isometric maximal voluntary contraction (MVC)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Both loads (30% and 60%)
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Load effect analysis
Number of subjects: 8
Study: 18496993

Group type: EXPERIMENTAL
Intervention: Auditory steady state response (ASSR) thresholds at 500 and 2000 Hz with a 46 Hz modulation rate
Number of subjects: 0

Group type: COMPARATOR
Intervention: Normal control group matched for age and hearing sensitivity
Number of subjects: 0
Study: 16269927

Group type: EXPERIMENTAL
Intervention: rFVIIa
Number of subjects: 25

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 25
Study: 12860867

Group type: EXPERIMENTAL
Intervention: 80 mg atorvastatin
Number of subjects: 325

Group type: COMPARATOR
Intervention: 40 mg simvastatin
Number of subjects: 325

Group type: COMPARATOR
Intervention: Comparison between atorvastatin and simvastatin
Number of subjects: 325
Study: 10365900

Group type: EXPERIMENTAL
Intervention: Erythromycin in normoglycaemia (200 mg intravenously)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Erythromycin in hyperglycaemia (200 mg intravenously)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo in normoglycaemia
Number of subjects: 12
Study: 10150850

Group type: EXPERIMENTAL
Intervention: Medical therapy and long-term laser treatment for capsular glaucoma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Surgical intervention for capsular glaucoma
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Capsular glaucoma
Number of subjects: 0
Study: 2132565

Group type: EXPERIMENTAL
Intervention: Folinic acid (leucovorin) supplementation given orally 4 hours after weekly low dose methotrexate administration
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 6110536

Group type: EXPERIMENTAL
Intervention: Active TBE-vaccination (purified TBE vaccine)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study: 30419888

Group type: EXPERIMENTAL
Intervention: Resilience Curriculum (RESCUR)
Number of subjects: 1000

Group type: EXPERIMENTAL
Intervention: Implementation in non-governmental organizations and social services groups
Number of subjects: 1000
Study: 27518188

Group type: EXPERIMENTAL
Intervention: EVA Park intervention (daily language stimulation sessions for 5 weeks)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Waitlist control group
Number of subjects: 20
Study: 25457315

Group type: EXPERIMENTAL
Intervention: Dynamic locking screw (DLS) with MIPO bridging technique
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard screws on both fracture sides
Number of subjects: 20
Study: 22398566

Group type: EXPERIMENTAL
Intervention: RM-1: pressure control ventilation for 1 min
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: RM-2: two hyperinflations with continuous positive airway pressure for 20 sec and 1 min interval in between
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: RM-3: three consecutive sighs
Number of subjects: 25
Study: 20643015

Group type: EXPERIMENTAL
Intervention: Levobupivacaine (5 mL of levobupivacaine hydrochloride, 25 mg/10 mL) soaked Merocele packs
Number of subjects: 41

Group type: COMPARATOR
Intervention: Saline soaked Merocele packs
Number of subjects: 41
Study: 18561542

Group type: EXPERIMENTAL
Intervention: Real articles (le, la, les, un, une, des)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Pseudo articles
Number of subjects: 0
Study: 15777102

Group type: EXPERIMENTAL
Intervention: Oxymorphone IR 5mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oxymorphone IR 10mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oxymorphone IR 20mg
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oxymorphone IR (steady state)
Number of subjects: 24

Group type: EXPERIMENTAL
Intervention: Oxymorphone IR (all doses)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Naltrexone hydrochloride (coadministered)
Number of subjects: 24
Study: 11818424

Group type: EXPERIMENTAL
Intervention: Aerobic Training (AT)
Number of subjects: 45

Group type: EXPERIMENTAL
Intervention: Resistance Training (RT)
Number of subjects: 45

Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 45
Study: 10959382

Group type: EXPERIMENTAL
Intervention: Losartan (Ocsaar) 50 mg daily, increased to 100 mg if necessary
Number of subjects: 421
Study: 9000839

Group type: EXPERIMENTAL
Intervention: Doxazosin therapy for 3 years
Number of subjects: 0

Group type: COMPARATOR
Intervention: Surgery
Number of subjects: 0
Study: 2201224

Group type: EXPERIMENTAL
Intervention: Normal-release dihydrocodeine
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Controlled-release dihydrocodeine
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 90
Study: 7280947

Group type: EXPERIMENTAL
Intervention: Parenteral cefamandole
Number of subjects: 113

Group type: EXPERIMENTAL
Intervention: Parenteral penicillin, gentamicin and clindamycin
Number of subjects: 113

Group type: COMPARATOR
Intervention: No parenteral antibiotics
Number of subjects: 113
Study: 29773354

Group type: EXPERIMENTAL
Intervention: Relaxation Response Resiliency Program (3RP)
Number of subjects: 109
Study: 29089058

Group type: EXPERIMENTAL
Intervention: Lotilaner (Credelio™)
Number of subjects: 195

Group type: COMPARATOR
Intervention: Fipronil/(S)-methoprene (FSM)
Number of subjects: 195
Study: 26078579

Group type: EXPERIMENTAL
Intervention: PUFA therapy (50 mL PUFA with 1:1 ratio of EHA and DHA added to daily diet)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: PUFA therapy
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study: 23566237

Group type: EXPERIMENTAL
Intervention: Autologous fibroblast treatment
Number of subjects: 99

Group type: COMPARATOR
Intervention: Vehicle control (cell culture medium)
Number of subjects: 99
Study: 21747047

Group type: EXPERIMENTAL
Intervention: Amlodipine
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Indapamide sustained release
Number of subjects: 577

Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 577

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 577
Study: 19623052

Group type: EXPERIMENTAL
Intervention: Daily exercise training session for 20 mins/day using a bedside cycle ergometer
Number of subjects: 90

Group type: COMPARATOR
Intervention: Standardized passive or active motion session of upper and lower limbs (Control group)
Number of subjects: 90
Study: 16786420

Group type: EXPERIMENTAL
Intervention: GnRH antagonist with low-dose hCG protocol (hCGP)
Number of subjects: 192

Group type: COMPARATOR
Intervention: GnRH antagonist with no low-dose hCG protocol (NhCGP)
Number of subjects: 192

Group type: COMPARATOR
Intervention: GnRH agonist (buserelin) long protocol (LP)
Number of subjects: 192